Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Lidocaine × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Lung Neoplasms 7 Carcinoma, Non-Small-Cell Lung 2 Tuberculosis 1 Sarcoidosis 1 Recurrence 1 Pneumonia 1 Pleural Effusion, Malignant 1 Malignant Pleural Neoplasm 1 Lung Diseases, Interstitial 1 Cough 1 Chronic Pain 1 Acute Pain 1

Interventions

Docetaxel 8 pembrolizumab 7 Pemetrexed 5 Carboplatin 5 Erlotinib Hydrochloride 4 toripalimab 3 rociletinib 3 Radiosurgery 3 Oxaliplatin 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Cisplatin 3 Bevacizumab 3 lorlatinib 2 fludarabine 2 atezolizumab 2 Vinorelbine 2 Topotecan 2 Radiotherapy 2 Platinum 2 Paclitaxel 2 Itraconazole 2 Irinotecan 2 Interleukin-2 2 Cyclophosphamide 2 Cetuximab 2 vinflunine 1 vandetanib 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡